IL18RAP and rheumatoid arthritis: In an independent replication data set of patients treated with csDMARDs with measured gene expression, the association between expression of IL18RAP and change in the ESR was confirmed in both whole blood and synovial tissue, highlighting IL18RAP as a gene worthy of further investigation for prediction of treatment response in RA that is not treatment-specific.